These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2564004)

  • 1. Postischemic administration of idazoxan, an alpha-2 adrenergic receptor antagonist, decreases neuronal damage in the rat brain.
    Gustafson I; Miyauchi Y; Wieloch TW
    J Cereb Blood Flow Metab; 1989 Apr; 9(2):171-4. PubMed ID: 2564004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against ischemia-induced neuronal damage by the alpha 2-adrenoceptor antagonist idazoxan: influence of time of administration and possible mechanisms of action.
    Gustafson I; Westerberg E; Wieloch T
    J Cereb Blood Flow Metab; 1990 Nov; 10(6):885-94. PubMed ID: 1976642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.
    Nellgård B; Wieloch T
    J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of nimodipine against ischemic neuronal damage in rat hippocampus without changing postischemic cerebral blood flow.
    Nuglisch J; Karkoutly C; Mennel HD; Rossberg C; Krieglstein J
    J Cereb Blood Flow Metab; 1990 Sep; 10(5):654-9. PubMed ID: 2384539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular brain cortical levels of noradrenaline in ischemia: effects of desipramine and postischemic administration of idazoxan.
    Gustafson I; Westerberg EJ; Wieloch T
    Exp Brain Res; 1991; 86(3):555-61. PubMed ID: 1684752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of delayed MK-801 (dizocilpine) treatment with or without immediate postischemic hypothermia on chronic neuronal survival after global forebrain ischemia in rats.
    Dietrich WD; Lin B; Globus MY; Green EJ; Ginsberg MD; Busto R
    J Cereb Blood Flow Metab; 1995 Nov; 15(6):960-8. PubMed ID: 7593357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idazoxan: a selective alpha 2-antagonist and effective sustained antidepressant in two bipolar depressed patients.
    Osman OT; Rudorfer MV; Potter WZ
    Arch Gen Psychiatry; 1989 Oct; 46(10):958-9. PubMed ID: 2572209
    [No Abstract]   [Full Text] [Related]  

  • 8. Intraischemic but not postischemic brain hypothermia protects chronically following global forebrain ischemia in rats.
    Dietrich WD; Busto R; Alonso O; Globus MY; Ginsberg MD
    J Cereb Blood Flow Metab; 1993 Jul; 13(4):541-9. PubMed ID: 8314910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the AMPA-receptor antagonist, NBQX, on neuron loss in dentate hilus of the hippocampal formation after 8, 10, or 12 min of cerebral ischemia in the rat.
    Hu P; Diemer NH; Bruhn T; Johansen FF
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):147-52. PubMed ID: 9040493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracoronary alpha 2-adrenergic receptor blockade attenuates ischemia in conscious dogs during exercise.
    Seitelberger R; Guth BD; Heusch G; Lee JD; Katayama K; Ross J
    Circ Res; 1988 Mar; 62(3):436-42. PubMed ID: 2893669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine treatment delays postischemic hippocampal CA1 loss after cardiac arrest and resuscitation in rats.
    Xu K; Puchowicz MA; Lust WD; LaManna JC
    Brain Res; 2006 Feb; 1071(1):208-17. PubMed ID: 16412392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury.
    Li H; Buchan AM
    J Cereb Blood Flow Metab; 1993 Nov; 13(6):933-9. PubMed ID: 7691852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat.
    Dennis T; L'Heureux R; Carter C; Scatton B
    J Pharmacol Exp Ther; 1987 May; 241(2):642-9. PubMed ID: 3033221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effects of the alpha 2-adrenoreceptor antagonist idazoxan on hormonal responses and symptoms of hypoglycaemia in patients with type 1 diabetes mellitus.
    Moberg E; Kollind M; Ostenson CG; Lins PE; Adamson U
    Diabetes Metab; 1996 Feb; 22(1):31-6. PubMed ID: 8697293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
    Boronat MA; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of peripheral beta-1 and alpha-2 receptor sensitivities by the administration of the tricyclic antidepressant, imipramine, alone and in combination with alpha-2 antagonists to rats.
    Keith RA; Howe BB; Salama AI
    J Pharmacol Exp Ther; 1986 Feb; 236(2):356-63. PubMed ID: 2868116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Subarachnoid administration of lidocaine reduces delayed neuronal damage due to forebrain ischemia in rats].
    Mizunuma T; Ohta S; Suzuki M
    Masui; 1996 Apr; 45(4):421-7. PubMed ID: 8725595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with alpha2-adrenoceptor antagonist, 2-methoxy idazoxan, protects 6-hydroxydopamine-induced Parkinsonian symptoms in rats: neurochemical and behavioral evidence.
    Srinivasan J; Schmidt WJ
    Behav Brain Res; 2004 Oct; 154(2):353-63. PubMed ID: 15313023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment but not posttreatment with GYKI 52466 reduces functional deficits and neuronal damage after global ischemia in rats.
    Block F; Schmitt W; Schwarz M
    J Neurol Sci; 1996 Aug; 139(2):167-72. PubMed ID: 8856648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological evidence for alpha-2 adrenoceptor heterogeneity: differential binding properties of [3H]rauwolscine and [3H]idazoxan in rat brain.
    Boyajian CL; Leslie FM
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1092-8. PubMed ID: 2885406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.